Advances and Prospect of Artificial Intelligence in Theranostics of Lung Cancer
The Clinical Lung Cancer · 26.03.2025
DOI: 10.52338/tclc.2025.4508 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Clinical Lung Cancer, online erschienen am 26.03.2025. Verfasst von Electrical Engineering und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lung cancer is the first cause of cancer death worldwide. How to realize precise theranostics and management of Lung cancer has huge clinical demand. In past decade, artificial intelligence (AI), especially machine learning (ML) and deep learning (DL) are broadly used in medicine. Herein we focus on reviewing the main advances of ML and DL in diagnosis, treatment and prognosis of lung cancer. Besides, we summarize AI’s advantages, explore how AI assists theranostics of lung cancer by innovative AI algorithms, then we discussed the opportunities and challenges as well as the future directions in the clinical implementation of AI in lung cancer. Overall, AI integrated with multidisciplinary technology and data is a new development trend, its application in theranostics of lung cancer owns excellent clinical transformation value and prospect in near future.
Zitieren
APA
Engineering, E., & Jiao, S. (2025). Advances and Prospect of Artificial Intelligence in Theranostics of Lung Cancer. The Clinical Lung Cancer. https://doi.org/10.52338/tclc.2025.4508
Vancouver
Engineering E, Jiao S. Advances and Prospect of Artificial Intelligence in Theranostics of Lung Cancer. The Clinical Lung Cancer. 2025. doi:10.52338/tclc.2025.4508
BibTeX
@article{Engineering2025,
author = {Engineering, Electrical and Jiao, Shanghai},
title = {Advances and Prospect of Artificial Intelligence in Theranostics of Lung Cancer},
journal = {The Clinical Lung Cancer},
year = {2025},
doi = {10.52338/tclc.2025.4508}
}
EUVIMED